Drag

Oral Antibiotics

Brand Logo
Brand Logo
Brand Logo

The oral antibiotics category includes prescription tablets used to treat bacterial infections of the skin and other body systems, strictly under medical supervision. Oral antibiotics such as amoxicillin-clavulanic acid combinations and cephalosporins are widely used for skin and soft tissue infections when bacterial involvement is confirmed or strongly suspected. Proper antibiotic selection, dose, and duration help maximize cure rates while limiting resistance and side effects. 

Key products

1. KLClav-625 Tablet – Amoxicillin-clavulanate combination tablet used in a range of community-acquired infections, including skin and soft tissue infections, as per guidelines. 

2. Xepibact 500 Tablet – Oral cephalosporin antibiotic tablet used where cephalosporins are indicated for susceptible bacterial infections. 

3. Sofidoxim 200 Tablet – Another cephalosporin-class option selected according to organism susceptibility, site of infection, and patient profile. 

Key active ingredients 

This segment mainly features β-lactam antibiotics, including amoxicillin–clavulanate and oral cephalosporins, which act by inhibiting bacterial cell wall synthesis. They are indicated only for confirmed or strongly suspected bacterial infections, not for viral illnesses, and must be taken for the full prescribed course. 

FAQ

Escalation is usually considered for extensive, refractory, or deeper infections, or when topical access is limited. Clinicians weigh organism suspicion, prior antibiotic exposure, and comorbidities before selecting systemic therapy and treatment duration.

They are commonly used in skin and soft‑tissue infections, acne variants, and specific pediatric infections where guidelines support systemic therapy. Use is generally protocol‑driven, with attention to stewardship and avoidance of unnecessary prolonged courses.

Prescribers typically stress adherence to the full course, timing with meals where relevant, and early reporting of allergic or severe gastrointestinal symptoms. Co‑prescription of probiotics or supportive measures is individualized based on patient risk.